Dear Sir,

We read with interest the recent report on gingival overgrowth due to amlodipine.[@bib0030] We would like to make a few remarks while sharing our experience with this condition in an elderly lady. While on amlodipine, she developed insidious gingival overgrowth ([Fig. 1](#fig0005){ref-type="fig"}) without any signs of inflammation. This was completely reversible which may not always be the case.[@bib0035]

'Overgrowth' is the preferred term rather than gingival hypertrophy.[@bib0040] Unattended, it may even lead to tooth loss. Treating and maintaining patients on amlodipine in periodontal practice involves considerable extra treatment and cost.[@bib0035] Overgrowth may not always be a class effect, because overgrowth has disappeared in a person who switched over to isradipine from nifedipine.[@bib0045] Half of the patients experience long-term recurrence.[@bib0035]

The pathogenesis is related to its mechanism of action. Amlodipine reduces Ca^2+^ cell influx, leading to a reduction in the uptake of folic acid, limiting the production of active collagenase.[@bib0050] Collagen is normally degraded by collagenases. Because of reduction in degradation, collagen accumulates in connective tissue matrix of gingiva.
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